The Spectrum of AI in Healthcare: Understanding the Levels of Intelligence in AI

Artificial intelligence (AI) is not just for gamers or factory warehouse robots—it can, quite literally, save lives in the healthcare sector. AI in healthcare can be used to improve diagnostic detection speed for diseases, improve personalization of medical treatments, and automate drug discoveries.

How should healthcare companies be approaching AI use, and what benefits and drawbacks can they expect to see when deploying AI?

On today’s episode of Iodine Intelligence, Empowering Intelligent Care, host Lauren Hickey, Content Strategist at Iodine Healthcare, is joined by Priti Shah, Chief Product & Technology Officer at Iodine Software, to discuss applications for AI in healthcare and how healthcare companies can approach use cases for AI models.

Hickey and Shah also discussed…

  • Applications of AI in automation, improving efficiency of judgement, timeliness, and consistency of results
  • A framework for guiding questions in approaching AI use
  • Real-world examples of how a company might answer questions about their AI

Shah knows AI in healthcare is not the end-all, be-all. “We have to understand that no model is perfect, and you have to choose one balance of false negatives and false positives you can live with.” She suggested, “One of the biggest things people should hone in on is how much data was this AI model trained on, and what is the quality and diversity of that data?”

Priti Shah is Chief Product & Technology Officer at Iodine Software. She is an experienced General Management Executive with more than two decades of experience in revenue growth and market expansion. Before her current role, Shah was Chief Product Officer of Finvi, VP, Product & Solutions at Wolters Kluwer Health, and VP, Product Strategy & Corporate Development, amongst other positions. Shah attended Harvard Business School’s General Management Program and the Rochester Institute of Technology, where she earned an MBA in Marketing & Strategic Management.

For More in This Series

Recent Episodes

Artificial intelligence software is increasing in complexity. Delivery models typically include traditional licensing or a managed service approach. The structure used to deploy these systems can influence how they operate in production environments. The CEO of Amberd, Mazda Marvasti, believes platforms at this level should be delivered as a managed service rather than under…

Providing managed AI services at a predictable, fixed cost can be challenging when hyperscaler pricing models require substantial upfront GPU commitments. Large upfront commitments and limited infrastructure flexibility may prevent providers from aligning costs with their delivery model. Amberd CEO Mazda Marvasti encountered this issue when exploring GPU capacity through Amazon. The minimum requirement…

Speed in business decisions is becoming a defining competitive factor. Artificial intelligence tools now allow smaller teams to analyze information and act faster than traditional organizations. Established companies face increasing pressure as decision cycles shorten across industries. Mazda Marvasti, CEO of Amberd, says new entrants are already using AI to accelerate business decisions. He…